Search clinical trials for: Ezetimibe + other lipid-lowering medication(s)

Total 39 results

Organon and Co
Bayer

Completed

A 52-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05245)

Hypercholesterolemia | Familial Hypercholesterolemia | Homozygous Sitosterolemia
Organon and Co
Bayer

Completed

A 12-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05244)

Hypercholesterolemia | Familial Hypercholesterolemia | Homozygous Sitosterolemia
Acasti Pharma Inc.
JSS Medical Research Inc.

Completed

Assess the Safety and Efficacy of NKPL66 (CaPre™) in the Treatment of Mild-to-high Hypertriglyceridemia

Hypertriglyceridemia

Canada
Samsung Medical Center

Unknown

Effects of Intensive Lipid Lowering and Omega-3 Fatty Acid on Composition of Coronary Atherosclerotic Plaque

Acute Coronary Syndrome

Korea, Republic of
Federal University of São Paulo

Completed

Effect of Simvastatin and Ezetimibe on Lipid and Inflammation

Inflammation | Hypercholesterolemia | Cardiovascular Risk | Prediabetes

Brazil
Osaka University
Kowa Company, Ltd.

Terminated

The Clinical Study of Pitavastatin Treatment for Group of Mild to Moderate Alzheimer's Disease (PIT-ROAD)

Alzheimer Disease | Hypercholesterolemia

Japan
Misr University for Science and Technology

Active, not recruiting

Investigate the Effect of Ezetimibe, Simvastatin, and Omega 3- Fatty Acids on Dyslipidemia Patients: a Pharmacokinetics Based Study

Hyperlipidemia; Mixed

Egypt
Organon and Co

Completed

An Investigational Drug Study to Lower Non-Cholesterol Sterol Levels Associated With Sitosterolemia (0653-062)(COMPLETED)

Heart Disease | Lipid Metabolism, Inborn Errors
Jose Rocha Faria Neto

Completed

Plant Sterols Effect on Previous Statin Therapy

Coronary Artery Disease

Brazil
Organon and Co

Withdrawn

A Study to Evaluate the Efficacy and Safety of Vytorin Versus Standard Treatment of Other Statins in Moderate, Moderately High and High Risk Participants (MK-0653A-406) (VYCTORY)

Dyslipidemia
Washington University School of Medicine
National Heart, Lung, and Blood Institute (NHLBI); Utah State University

Completed

Phytosterols, Ezetimibe, and Cholesterol Metabolism (Phyteaux-III)

Hypercholesterolemia | Coronary Heart Disease

United States
University of Manitoba

Completed

Sitosterolemia Metabolism (STAIR7002)

Sitosterolemia

Canada
GWT-TUD GmbH

Active, not recruiting

Prospective German Very High Cardiovascular Risk Patients Dyslipidemia Treatment Indication Registry (PERI-DYS)

Dyslipoproteinemias

Germany
Gregory Graf, PhD

Terminated

Ezetimibe-Ursodiol Combination Therapy on Biomarkers of Liver Function and Sterol Balance in Subjects With NAFLD

Nonalcoholic Fatty Liver Disease (NAFLD)

United States
Mark Stegall
Janssen Scientific Affairs, LLC

Active, not recruiting

Janssen Ad26.CoV2.S Vaccine Booster in Kidney Transplant Recipients

Kidney Transplant Recipient

United States
Akrikhin
Russian National Atherosclerosis Society

Completed

Statin Monotherapy or Statins in Combination With Ezetimibe in Patients for Prevention of CVD (UNISON)

Cardiovascular Diseases | Lipid Metabolism Disorders

Russian Federation
National Heart, Lung, and Blood Institute (NHLBI)

Completed

SCH-58235 (Ezetimibe) to Treat Homozygous Sitosterolemia

Lipoidosis

United States
Instituto Nacional de Ciencias Medicas y Nutricion...
Merck Sharp & Dohme LLC

Withdrawn

Efficacy of Ezetimibe/Simvastatin 10/20 mg and MK0524A (1-2 g/Day) in Mixed Hyperlipidemia and Two or More Risk Factors

Cardiovascular Diseases | Hyperlipidemia
Junbo Ge
Fujian Medical University; Health Science Center of Xi'an Jiaotong University; The Second Affiliated Hospital of Harbin Medical University and other collaborators

Unknown

Intensive Education on Lipid Management

Acute Coronary Syndrome

China
Seoul National University Bundang Hospital
Korea United Pharm. Inc.

Recruiting

Atmeg (Atorvastatin and Omega-3 Combination) and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia

Diabetes Mellitus, Type 2 | Atherosclerosis | Dyslipidemias

Korea, Republic of
University of Roma La Sapienza

Unknown

Cholesterol-lowering Effects of nutraceuticaLs Versus Ezetimibe in Statin-intolerant Patients (CHOLESS)

Coronary Artery Disease

Italy
Yonsei University

Completed

Effect of Lipid Modifying Drugs on HDL Function in Patients With Hyperlipidemia

Hyperlipidemia

Korea, Republic of
University of Southern California
InterHealth Nutraceuticals, Inc.

Terminated

Supplements for Controlling Resistance to Insulin (SCORE)

Obesity | Diabetes Mellitus, Type 2

United States
University of Manitoba
Canadian Institutes of Health Research (CIHR)

Completed

Can Cholesterol Lowering Drugs Influence Circulating Omega-3 Fatty Acid Levels

Hypercholesterolemia | Hyperlipidemia

Canada
VA Office of Research and Development

Completed

Plaque Regression and Progenitor Cell Mobilization With Intensive Lipid Elimination Regimen (PREMIER), Phase II (PREMIER)

Acute Coronary Artery Syndrome

United States
VA Office of Research and Development

Completed

Plaque Regression and Progenitor Cell Mobilization With Intensive Lipid Elimination Regimen (PREMIER), Phase I (PREMIER)

Acute Coronary Syndrome

United States
Sanofi
Regeneron Pharmaceuticals

Completed

An 8-Week Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (ODYSSEY KIDS)

Hypercholesterolaemia

Norway, Russian Federation, Sweden, South Africa, Czechia, United States, Canada, France, Netherlands, Spain
Integrative Health Technologies, Inc.

Unknown

Study of Changes in Total Cholesterol Levels as a Function of Consuming a Supplement Designed to Improve Cardiovascular Health (AdBiotech)

Hyperlipidemia | Hypercholesteremia | Cholesterol

United States
Nehal Abou Seada

Completed

Efficacy of Phosphatidylcholine in NAFLD

Non-Alcoholic Fatty Liver Disease
Sanofi
Regeneron Pharmaceuticals

Completed

Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)

Dyslipidemia

United States, Australia, Brazil, Finland, Germany, Israel, Italy, Kuwait, Lebanon, Norway, Sweden, Switzerland, Turkey, United Arab Emirates, United Kingdom
University of Louisville

Recruiting

Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP) (ARTCAP)

Coronary Artery Disease | Atherosclerosis, Coronary

United States
Jun Cheng
Sanofi; Fujian Cosunter Pharmaceutical Co. Ltd

Unknown

Study of Effects and Safety Between Adefovir Dipivoxil Plus Polyene Phosphatidylcholine Versus Adefovir Dipivoxil Alone in Chronic Hepatitis B Patients

Chronic Hepatitis B

China
University of Michigan

Completed

Predictors of Antidepressant Response

Depression

United States
Sanofi
Regeneron Pharmaceuticals

Completed

An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia

Hypercholesterolaemia

Czechia, France, Denmark, Netherlands, Austria, Mexico, Spain, United States, Argentina, Brazil, Bulgaria, Canada, Finland, Hungary, Italy, Lebanon, Norway, Poland, Russian Federation, Slovenia, South Africa, Sweden, Taiwan, Turkey
Sanofi
Regeneron Pharmaceuticals

Completed

An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia

Hypercholesterolemia

Slovenia, Taiwan, Russian Federation, Canada, Netherlands, Brazil, Denmark, Mexico, Spain, Turkey
Beni-Suef University
University of Arizona; Maternity and Children Hospital, Makkah; Benisuef university...

Completed

Different Treatment Modalities in the Management of the Painful Crisis in Pediatric Sickle- Cell Anemia

Sickle Cell Disease | Vaso-occlusive Crisis | Sickle Cell Anemia in Children

Egypt, Saudi Arabia
The Canadian College of Naturopathic Medicine
Canada Post Corporation; Canadian Union of Postal Workers

Completed

Naturopathic Treatment for the Prevention of Cardiovascular Disease (Cardio pilot)

Cardiovascular Disease

Canada
University of Iowa
DJO Incorporated; Direct MS Canada; Pinnaclife Inc.; TZ Press, LLC

Completed

Nutrition, Neuromuscular Electrical Stimulation (NMES) and Secondary Progressive Multiple Sclerosis (SPMS)

Multiple Sclerosis

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Low-Intensity Chemotherapy and Venetoclax in Treating Patients With Relapsed or Refractory B- or T-Cell Acute Lymphoblastic Leukemia

Recurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Refractory T Acute Lymphoblastic Leukemia | Recurrent T Acute Lymphoblastic Leukemia

United States

Search clinical trials for: Ezetimibe + other lipid-lowering medication(s)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uruguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations